News

Filter

Current filters:

Faslodex

1 to 9 of 37 results

News briefs: Bayer's Stivarga and AstraZeneca's Faslodex

30-10-2012

German drug major Bayer (BAYN: DE) and US partner Onyx Pharmaceuticals (Nasdaq: ONXX) said yesterday…

AstraZenecaBayerFaslodexNorth AmericaOncologyOnyx PharmaceuticalsPharmaceuticalRegulationResearchStivarga

Drug combo better for common type of metastatic breast cancer

02-08-2012

Postmenopausal women with the most common type of metastatic breast cancer now have a new treatment option…

ArimidexAstraZenecaFaslodexOncologyPharmaceuticalResearch

Mixed NICE views on Faslodex and RoActemra

14-12-2011

There was mixed news this morning from the UK’s National Institute for Health and Clinical Excellence…

Anti-Arthritics/RheumaticsAstraZenecaEuropeFaslodexOncologyPharmaceuticalPricingRegulationRoActemraRoche

UK’s NICE says no to AstraZeneca breast cancer drug Faslodex

10-11-2011

There was negative news this morning for Anglo-Swedish drug major AstraZeneca (LSE: AZN), when the UK’s…

AstraZenecaEuropeFaslodexOncologyPharmaceuticalPricingRegulation

AstraZeneca breast cancer drug Faslodex not good use of NHS resources, says NICE draft guidance

24-08-2011

An independent committee of experts that develops guidance on behalf of the UK drugs watchdog the National…

AstraZenecaEuropeFaslodexOncologyPharmaceuticalPricingRegulation

1 to 9 of 37 results

Back to top